Resume (Education and Working Experience)

Education：

1. 2016 Wenzhou Medical University, Bachelor of Medicine in Clinical Medicine
2. 2019 Wenzhou Medical University, Master of Medicine in Neurology
3. 2022 The Chinese University of Hong Kong, PhD in Chinese Medicine

Working Experience：

1. 2022-Present, Research Assistant, School of Chinese Medicine, The Chinese University of Hong Kong  

Research Interest

1. Target Understandings and Drug Discovery for Triple-negative Breast Cancer

Publications

1. Xu QQ, Su ZR, Hu Z, Yang W, Xian YF, Lin ZX. Patchouli alcohol ameliorates the learning and memory impairments in an animal model of Alzheimer's disease via modulating SIRT1. Phytomedicine. 2022 Sep 6;106:154441.
2. Xu QQ, Shaw PC, Hu Z, Yang W, Ip SP, Xian YF, Lin ZX. Comparison of the chemical constituents and anti-Alzheimer's disease effects of Uncaria rhynchophylla and Uncaria tomentosa. Chin Med. 2021 Oct 27;16(1):110.
3. Xu QQ, Shan CS, Wang Y, Shi YH, Zhang QH, Zheng GQ. Chinese Herbal Medicine for Vascular Dementia: A Systematic Review and Meta-Analysis of High-Quality Randomized Controlled Trials. J Alzheimers Dis. 2018;62(1):429-456.
4. Chen ZX*, Xu QQ*, Shan CS, Shi YH, Wang Y, Chang RC, Zheng GQ. Borneol for Regulating the Permeability of the Blood-Brain Barrier in Experimental Ischemic Stroke: Preclinical Evidence and Possible Mechanism. Oxid Med Cell Longev. 2019 Feb 4;2019:2936737.
5. Li Y*, Xu QQ*, Shan CS, Shi YH, Wang Y, Zheng GQ. Combined Use of Emodin and Ginsenoside Rb1 Exerts Synergistic Neuroprotection in Cerebral Ischemia/Reperfusion Rats. Front Pharmacol. 2018 Aug 28;9:943.